• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » February 2004 – The CenterWatch Monthly : volume 11, Issue 2, February 2004
February 2004 – The CenterWatch Monthly : volume 11, Issue 2, February 2004

February 2004 – The CenterWatch Monthly : volume 11, Issue 2, February 2004

$79.00

Product Details

Taking Patient Recruitment In-House

More than one-third of top sponsors have created in-house recruitment functions and another 25% report that they are now planning to do so. Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Procter & Gamble, and GlaxoSmithKline have all made significant strides in centralizing their patient recruitment initiatives. BMS’ Tour of Hope campaign is on the leading edge of these initiatives.

International Enthusiasm for EDC

Use of EDC in clinical trials and support for CDISC standards are now growing at a faster pace in Western Europe and Japan than in North America. International sponsors and investigative sites report having had more positive experiences with EDC. Japan, in particular, reports extremely high hopes to rein in clinical trial expenses using eCT technologies.

Building Momentum for Europe’s Pediatric Clinical Trials

More than 75 million people in Europe are under the age of 19, and the European Agency for the Evaluation of Medicinal Products (EMEA) estimates at least 50% of drugs used for children are used off-label or on an unlicensed basis. In response, the European Commission aims to implement legislation regulating drugs for pediatric use as outlined in its 2001 draft proposals: Better Medicines For Children.

Eye On: Epilepsy

Epilepsy affects 2.5 million Americans and 40 million people worldwide. CenterWatch has identified a pipeline of 12 drugs in development for epilepsy.

  • Month in Review
  • In the Pipeline
  • Opportunities Underway
  • TrialWatch
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing